首页|他汀类药物不良反应的临床分析

他汀类药物不良反应的临床分析

Adverse Reactions Induced by Statins:A Clinical Analysis

扫码查看
目的 通过分析他汀类药物不良反应报告,为合理使用他汀类药物及不良反应预防提供依据.方法 收集从2011-2021年某医院的他汀类药物不良反应报告,依据帕累托分类原则,统计他汀类药物不良反应的类型以及患者的基本情况,分析可能的影响因素以及结局等.结果 共收集147例他汀类药物的不良反应报告,他汀类药物不良反应发生人群中55岁以上患者占73.47%;不同年龄合并用药数量:65岁以上为14.29±3.77种,55~65岁为10.50±2.31种;报告中肝损伤占比最高(70.07%),其他还有肌肉、皮肤和神经系统等方面的不良反应;不良反应发生的中位时间为4 d;引起不良反应的主要药物为阿托伐他汀40 mg·d-1、阿托伐他汀20 mg·d-1 以及瑞舒伐他汀10 mg·d-1;多数患者持续时间在9 d以内(72.79%);63例患者痊愈(42.86%),71例患者好转(48.30%).结论 使用他汀类药物时,对于55岁以上人群,应尽量精简药物使用种类,避免增加剂量的强化降脂方案,使用4 d左右时应注意监测肝功能指标以及其他不良反应,如有发生应及时停药治疗,多数可好转或痊愈.
Objective To provide data for rational use of statins and prevention of adverse drug reac-tions(ADR).Methods Reports of ADR of statins from 2011 to 2021 were collected.According to the Pareto principle,the types of ADR of statins,basic data of patients,possible influencing factors and outcomes were analyzed.Results A total of 147 ADR of statins were reported and 73.47%of the patients were over 55.The number of combined drugs was 14.29±3.77 for patients over 65,and 10.50±2.31 for those ages 55 to 65.The percentage of liver damage was the highest(70.07%),with other adverse effects manifested in the muscle,skin and nervous system.The median duration of ADR was 4 days.Drugs that were chiefly responsible for these ADR were atorvastatin 40 mg·d-1,atorvastatin 20 mg·d-1,and rosu-vastatin 10 mg·d-1.The duration of ADR was less than 9 d(72.79%)in most of the patients,among who 63 recovered(42.86%)and 71 improved(48.30%).Conclusion When statins are used in patients over 55 years old,clinicians should minimize the drug regimen and avoid prescribing intensive lipid-lower-ing satins.Liver function indicators and other ADR should be monitored four days into the medication.Statins should be withdrawn in case of ADR.

statinsadverse drug reactionPARETO analysis

张岩、刘鑫、邓娇、李炎君、佟嫱、陈菡、任天舒、赵明沂、党大胜

展开 >

110016 辽宁沈阳,北部战区总医院

110016 辽宁沈阳,沈阳药科大学

他汀类药物 不良反应 帕累托分析

2024

解放军药学学报
中国人民解放军总后勤部卫生部 药品仪器检验所

解放军药学学报

影响因子:0.529
ISSN:1008-9926
年,卷(期):2024.37(3)